Drug companies often deny patients access to experimental treatments for rare diseases. Here’s why

Drug companies often deny patients access to experimental treatments for rare diseases. Here’s why

Even with experimental treatments on the rise, patients with rare diseases frequently face an unwillingness by drug companies to provide ...
The potential downside of genetic health screenings

The potential downside of genetic health screenings

Kaiser Family Foundation Health News | 
Doctors are increasingly testing people’s genes for signs of hereditary risks for cancer, said Dr. Allison Kurian, a medical oncologist ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists